Analysis of β-agonists by HPLC/ESI-MSn in horse doping control

Biomedical Chromatography

Volumn 25, Issue 1, 2011, Pages 147-154

  Garcia, P ^a   Paris, A C ^a   Gil, J ^a   Popot, M A ^a   Bonnaire, Y ^a  

^a LCH   (France)

Author keywords

Horse urine; SPE extraction; agonists

Indexed keywords

BODY FLUIDS; PHASE SEPARATION;

DOPING CONTROL; FENOTEROL; FORMOTEROL; HORSE URINE; HPLC-ESI MS; LC-ESI-MS; LC/ESI-MS; SENSITIVE METHOD; SPE EXTRACTION; Β-AGONIST;

EXTRACTION;

CIMATEROL; CLENBUTEROL; FENOTEROL; FORMOTEROL; MABUTEROL; RACTOPAMINE; SALBUTAMOL; SALMETEROL; TERBUTALINE;

ANALYZER; ARTICLE; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; DOPING; DRUG DETERMINATION; DRUG STRUCTURE; DRUG URINE LEVEL; ELECTROSPRAY MASS SPECTROMETRY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HORSE; LOW DRUG DOSE; NONHUMAN; SENSITIVITY ANALYSIS; SOLID PHASE EXTRACTION; URINALYSIS; VALIDATION PROCESS;

EQUIDAE;

EID: 78650639176     PISSN: 02693879     EISSN: 10990801     Source Type: Journal    
DOI: 10.1002/bmc.1562     Document Type: Article

References (17)

1. Damasceno L, Ventura R, Cardoso J and Segura J. Diagnostic evidence for the presence of β-agonists using two consecutive derivatization procedures and gas chromatography-mass spectrometry analysis. Journal of Chromatography B 2002; 780: 61-71.
2. 2-agonists in urine by fast-gas chromatography mass spectrometry: method validation and clinical application. Biomedical Chromatography 2010; 24: 358-366.
3. Dumasia MC and Houghton E. Screening and confirmatory analysis of β-agonists, β-antagonists and their metabolites in horse urine by capillary gas chromatography-mass spectrometry. J of Chromatography 1991; 564: 503-513.
4. Guan F, UBoh C E, Soma L R, Luo Yi, Li R, Birks E K, Teleis D, Rudy Ja and Tsang DS. Quantification of clenbuterol in equine plasma, urine, and tissue by liquid-chromatography coupled on-line with quadrupole time of flight mass spectrometry. Rapid Communications in Mass Spectrometry 2002; 16: 1642-1651.
5. Harkins JD, Woods WE, Lehner AF, Fisher M and Tobin T. Clenbuterol in the horse: urinary concentrations determined by ELISA and GC/MS after clinical doses. Journal of Veterinary Pharmacology and Therapeutics 2001; 24: 7-14.
6. Jimenez C, Ventura R and Segura J. Validation of qualitative chromatographic methods: strategy in antidoping control laboratories. Journal of Chromatography B 2002; 767: 341-351.
7. Ladaga GJB, Lebiza FP, Ferraro G and De Erausquin GA. Some pharmacodynamic effects of eformeterol in the horse. Journal of Veterinary Pharmacology and Therapeutics 2000; 30: 496-499.
8. Lehner AF, Harkins JD, Karpiesiuk W, Woods WE, Robinson NE, Dirikolu L, Fisher M, Tobin T. Clenbuterol in the horse: confirmation and quantitation of serum clenbuterol by LC-MS-MS after oral and intratracheal administration. J Anal Toxicol 2001; 25: 280-287.
9. Lehner AF, Hughes CG, Harkins JD, Nickerson C, Molett B, Dirikolu L, Bosken J, Camargo F, Boyles J, Troppmann A, Karpiesiuk W, Woods WE and Tobin T. Detection and confirmation of ractopamine and its metabolites in horse urine after Paylean administration. Journal of Analytical Toxicology 2004; 28: 226-238.
10. Nielen MWF, Lasaroms JJP, Essers ML, Oosterrink JE, Meijer T, Sanders MB, Zuidema T and Stolker AAM. Multi-residue analysis of beta-agonists in bovine and porcine urine feed and hair using liquid chromatography electrospray ionization tandem mass spectrometry. Analytical Bioanalytical Chemistry 2008; 309: 199-210.
11. 2-agonists by hyphenated chromatographic and mass spectrometric techniques. Journal of Chromatography B 1996; 687: 27-42.
12. Popot MA, Stojiljkovic N, Garcia P, Bonnaire Y and Tabet JC. First mass spectrometric detection of boldenone in horse mane samples. Chromatographia 2003; 57: 255-260.
13. 2-agonists in human or equine urine. Journal of Mass Spectrometry, 2003; 38:1196-1206.
14. 2. Biomedical Chromatography 2002a; 16: 475-481.
15. Van Eenoo P, Deventer K and Delbeke FT. Quantitative detection of salmeterol after inhalation in equine urine by liquid chromatography/tandem mass spectrometry. Rapid Communications in Mass Spectrometry 2002b; 16: 1755-1759.
16. Van Hoof N, Courtheyn D, Antignac JF, Van de Wiele M, Poelmans S, Noppe H and De Brabander H. Multi-residue liquid chromatography/tandem mass spectrometric analysis of beta-agonists in urine using molecular imprinted polymers. Rapid Communications in Mass Spectrometry 2005; 19: 2801-2808.
17. Zamecnik J. Use of cyclic boronates for GC/MS screening and quantitation of beta-adrenergic blockers and some bronchodilators. Journal of Analytical Toxicology 1990; 14: 132-136.